Item 120

Authorize to make a retroactive, sole source amendment to G&C Item #62, approved August 13, 2025, archived document , for the purchase of pharmaceuticals through McKesson Pharmaceuticals, Methuen, MA utilizing a class exception waiver approved by DAS, by extending the end date from May 31, 2026, to May 31, 2031, and increasing the price limitation from $1,000,000 to $7,200,000. Effective upon G&C approval through May 31, 2031. 60% General Funds, 40% Federal Funds